Clinical Trial Update: Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX [Phase 2]

View source ↗

Summary

Phase 2 trial comparing adherence to HIV therapy between oral medication and extended-release naltrexone in individuals with heroin addiction; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• XR-NTX (naltrexone extended-release injectable)
• oral therapy

Snippet

Sponsor: University of Pennsylvania | Conditions: HIV, Substance Abuse | Phase 2 | Status: COMPLETED